These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12048993)

  • 1. Spinning out a star.
    Lord MD; Mandel SW; Wager JD
    Harv Bus Rev; 2002 Jun; 80(6):115-21, 154. PubMed ID: 12048993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gurus in the garage.
    Leonard D; Swap W
    Harv Bus Rev; 2000; 78(6):71-3, 76-80, 82. PubMed ID: 11184978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discipline of innovation.
    Drucker PF
    Harv Bus Rev; 1998; 76(6):149-57. PubMed ID: 10187245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bootstrap finance: the art of start-ups.
    Bhide A
    Harv Bus Rev; 1992; 70(6):109-17. PubMed ID: 10122688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why entrepreneurs don't scale.
    Hamm J
    Harv Bus Rev; 2002 Dec; 80(12):110-5, 134. PubMed ID: 12510543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building breakthrough businesses within established organizations.
    Govindarajan V; Trimble C
    Harv Bus Rev; 2005 May; 83(5):58-68, 152. PubMed ID: 15929404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bringing Silicon Valley inside.
    Hamel G
    Harv Bus Rev; 1999; 77(5):70-84, 183. PubMed ID: 10621268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ideal physician entrepreneur.
    Bottles K
    Physician Exec; 2000; 26(6):55-8. PubMed ID: 11187408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Empire strikes back. Counterrevolutionary strategies for industry leaders.
    D'Aveni R
    Harv Bus Rev; 2002 Nov; 80(11):66-74, 133. PubMed ID: 12422790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why business models matter.
    Magretta J
    Harv Bus Rev; 2002 May; 80(5):86-92, 133. PubMed ID: 12024761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making sense of corporate venture capital.
    Chesbrough HW
    Harv Bus Rev; 2002 Mar; 80(3):90-9, 133. PubMed ID: 11894386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funding growth in an age of austerity.
    Hamel G; Getz G
    Harv Bus Rev; 2004; 82(7-8):76-84, 186. PubMed ID: 15241954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-market innovation.
    Rigby D; Zook C
    Harv Bus Rev; 2002 Oct; 80(10):80-9, 129. PubMed ID: 12389463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care entrepreneurship: financing innovation.
    Grazier KL; Metzler B
    J Health Hum Serv Adm; 2006; 28(4):485-503. PubMed ID: 16583848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How open innovation can help you cope in lean times.
    Chesbrough HW; Garman AR
    Harv Bus Rev; 2009 Dec; 87(12):68-76, 128. PubMed ID: 19968058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2002 HBR list. Breakthrough ideas for today's business agenda.
    Harv Bus Rev; 2002 Mar; 80(3):58-66, 132. PubMed ID: 11894383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leadership journey.
    Schaeffer LD
    Harv Bus Rev; 2002 Oct; 80(10):42-7, 127. PubMed ID: 12389460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastering the value chain. An interview with Mark Levin of Millennium Pharmaceuticals. Interview by David Champion.
    Levin M
    Harv Bus Rev; 2001 Jun; 79(6):108-15, 148. PubMed ID: 11408971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The strategic power of saying no.
    Bishop S
    Harv Bus Rev; 1999; 77(6):50-3, 56-61, 215. PubMed ID: 10662005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.